CompletedPhase 4

Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception

Thailand69 participantsStarted 2017-01-21

Plain-language summary

Quick starting combined oral contraception containing estradiol hemihydrate/nomegestrol acetate is effective to inhibit ovulation in healthy reproductive age women and non-inferiority to combined oral contraception containing ethinyl estradiol/gestodene.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy women, age 18 - 40 years * prior normal and regular interval of menstruation Exclusion Criteria: * current breast feeding women * within 1 month period of child-delivery or miscarriage * body mass index 30 kg/m2 or more * contraindicated to use combined hormonal contraception * current using other hormonal drugs that affect ovulation function

What they're measuring

ovulation inhibition

Timeframe: 1 month

Trial details

NCT IDNCT03077555

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-02-28

View on ClinicalTrials.gov More Ovulation Inhibition trials